- Home
- SRM vs SNGX Comparison
SRM vs SNGX Comparison
Compare SRM & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- SNGX
- Stock Information
- Founded
- SRM 1979
- SNGX 1987
- Country
- SRM United States
- SNGX United States
- Employees
- SRM N/A
- SNGX N/A
- Industry
- SRM
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- SNGX Health Care
- Exchange
- SRM Nasdaq
- SNGX Nasdaq
- Market Cap
- SRM 9.0M
- SNGX 7.4M
- IPO Year
- SRM 2023
- SNGX 1987
- Fundamental
- Price
- SRM $0.79
- SNGX $2.43
- Analyst Decision
- SRM
- SNGX
- Analyst Count
- SRM 0
- SNGX 0
- Target Price
- SRM N/A
- SNGX N/A
- AVG Volume (30 Days)
- SRM 17.4M
- SNGX 31.1K
- Earning Date
- SRM 03-31-2025
- SNGX 03-14-2025
- Dividend Yield
- SRM N/A
- SNGX N/A
- EPS Growth
- SRM N/A
- SNGX N/A
- EPS
- SRM N/A
- SNGX N/A
- Revenue
- SRM $4,594,304.00
- SNGX $364,183.00
- Revenue This Year
- SRM N/A
- SNGX N/A
- Revenue Next Year
- SRM N/A
- SNGX $76.64
- P/E Ratio
- SRM N/A
- SNGX N/A
- Revenue Growth
- SRM N/A
- SNGX N/A
- 52 Week Low
- SRM $0.30
- SNGX $1.83
- 52 Week High
- SRM $1.85
- SNGX $14.88
- Technical
- Relative Strength Index (RSI)
- SRM 66.62
- SNGX 46.06
- Support Level
- SRM $0.30
- SNGX $2.35
- Resistance Level
- SRM $0.93
- SNGX $2.47
- Average True Range (ATR)
- SRM 0.08
- SNGX 0.13
- MACD
- SRM 0.07
- SNGX 0.04
- Stochastic Oscillator
- SRM 62.33
- SNGX 61.36
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).